Intocell Inc (287840) Stock Price & News

Why is 287840 down 3.08%?

Dive Deeper

287840:KOSDAQ

Intocell Inc

₩12,890.00

-3.08%

(-410.00) 1D

Nov 13, 3:30:17 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 287840...

Open

₩13,110

High

₩13,730

Low

₩12,640

Mkt. cap

193.63B

Avg. vol.

32.08K

Volume

20.04K

52-wk high

₩74,900

52-wk low

₩12,400

EPS

-₩631

Shares outstanding

15.02M

No. of employees

Open

₩13,110

High

₩13,730

Low

₩12,640

Mkt. cap

193.63B

Avg. vol.

32.08K

Volume

20.04K

52-wk high

₩74,900

52-wk low

₩12,400

EPS

-₩631

Shares outstanding

15.02M

No. of employees

Related stocks

475830

Orum Therapeutics Inc

News stories

From web sources and news partners

Yahoo Finance

23 minutes ago

Stock market today: Dow, S&P 500, Nasdaq futures waver as Nvidia tumult deepens

Reuters

17 minutes ago

Nasdaq futures dip as Nvidia tumult keeps investors on edge

Bloomberg.com

1 hour ago

Goldman Sees S&P 500 Rising 14% on Cheap Hyperscaler Valuations

CNBC

21 minutes ago

Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump

About Intocell Inc

CEO-

Employees43

Founded2015

Headquarters-

SectorHealth Care

IndustryBiotechnology

Websiteintocell.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.42B	728.05M	281.15M	760.30M
Cost of goods sold	2.53M	1.37M	606.18K	4.14M
Cost of revenue	2.53M	1.37M	606.18K	4.14M
Research and development expenses	2.25B	-2.26B	3.08B	2.03B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	396.73M	4.25B	685.70M	871.99M
Operating expense	2.72B	2.60B	3.81B	2.96B
Total operating expenses	2.72B	2.60B	3.81B	2.97B
Operating income	-1.30B	-1.87B	-3.53B	-2.21B
Other non operating income	-19.30K	-485.69M	-614.33M	-42.29K
EBT including unusual items	-1.14B	-2.23B	-4.01B	-2.07B
EBT excluding unusual items	-1.14B	-2.20B	-4.01B	-2.07B
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	8.34M	11.12M	6.73M	6.67M
Net income	-1.14B	-2.23B	-4.01B	-2.07B
Net profit margin	-79.87%	-306.17%	-1,426.12%	-272.42%
Earnings per share	-	-	-	-
Interest and investment income	251.37M	226.07M	216.61M	208.91M
Interest expense	-65.99M	-66.95M	-80.33M	-70.67M
Net interest expenses	185.38M	159.12M	136.28M	138.23M
Depreciation and amortization charges	64.98M	352.12M	39.37M	53.59M
EBITDA	-1.10B	-1.66B	-3.35B	-2.00B
Gain or loss from assets sale	-	-	2.00K	-2.00K

Ask anything